Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A

Mediolanum International Funds Ltd lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 34.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,206 shares of the medical research company’s stock after selling 15,620 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Agilent Technologies were worth $3,738,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in A. Norges Bank bought a new position in shares of Agilent Technologies in the second quarter valued at approximately $395,088,000. AQR Capital Management LLC boosted its holdings in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. grew its position in shares of Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares during the period. Finally, Troy Asset Management Ltd raised its position in shares of Agilent Technologies by 74.3% in the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after buying an additional 1,021,865 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,401 shares of company stock valued at $2,468,962 over the last 90 days. 0.26% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently commented on A. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. Wells Fargo & Company lifted their price target on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. TD Cowen upped their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Morgan Stanley began coverage on shares of Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Finally, HSBC started coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $164.50.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $135.52 on Tuesday. The stock has a market cap of $38.42 billion, a price-to-earnings ratio of 29.65, a P/E/G ratio of 3.89 and a beta of 1.29. The stock’s 50-day moving average is $141.87 and its 200 day moving average is $134.82. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the firm posted $1.46 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th were paid a $0.255 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend was Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.